DOVA- To host investor and analyst day 9/20:
September 11, 2018
PDF Version
DURHAM, N.C., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a specialty pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where there is a high unmet need, today announced that the Company will host a live webcast of its Investor & Analyst Day on Thursday, September 20, 2018 beginning at 7:30 a.m. ET in New York City.
Key opinion leaders will discuss their own experiences with DOPTELET® (avatrombopag). In addition, another key opinion leader will discuss the potential opportunities for DOPTELET in additional indications if approved by the U.S. Food and Drug Administration, including immune thrombocytopenia (ITP) and chemotherapy-induced thrombocytopenia (CIT).
In-person attendance requires advance registration. If you would like to attend in-person, please send a RSVP to john.woolford@westwicke.com or call (443) 213-0506.
The live audio webcast of the event will be available through the “Investor Relations” page of the Dova website, www.dova.com. To access the webcast, please log on through Dova's website approximately 10 minutes before the scheduled start time. A replay of the webcast will be archived on Dova’s website for 90 days following the event.
Emil Nolde
